Extended Data Fig. 5: Recombinant G-CSF treatment permits controlled neutrophil recruitment.

a, Experimental setup for rG-CSF time course. Mice were given a subcutaneous injection of rGCSF every second day for a total of 4 doses, beginning the day before irradiations. On day 0, 2, 4, 6, 7 and 8, a blood sample was taken from each mouse to quantify Ly6G+ neutrophils. Mice were harvested at day 8. b, FACS analysis of Ly6G+CD11b+ neutrophils among CD45+ cells in the blood (n = 6 mice per group). The day of rGCSF injections is depicted in blue and indicated by an arrow. The day of irradiation (day 0), the day of cancer cell injection (day 7) and the day of lung seeding (day 8) are indicated. Each dot represents an individual mouse, treated with either rGCSF (blue dots) or PBS (black dots). IV, intravenous; rG-CSF, recombinant G-CSF; ko, knock-out.